7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Antibiotic-tolerant Staphylococcus aureus Biofilm Persists on Arthroplasty Materials

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The continued presence of biofilm may be one cause of the high risk of failure observed with irrigation and débridement with component retention in acute periprosthetic joint infection (PJI). There is a poor understanding of the role of biofilm antibiotic tolerance in PJI.

          Questions/purposes

          (1) Do increasing doses of cefazolin result in decreased viable biofilm mass on arthroplasty materials? (2) Is cefazolin resistance phenotypic or genotypic? (3) Is biofilm viability a function of biofilm depth after treatment with cefazolin? (4) Is the toxin-antitoxin system, yoeB expression, associated with antibiotic stress?

          Methods

          Methicillin-sensitive Staphylococcus aureus biofilm was cultured on total knee arthroplasty (TKA) materials and exposed to increasing doses of cefazolin (control, 0.5, 1.0, 10.0, 100.0 μg/mL). Quantitative confocal microscopy and quantitative culture were used to measure viable biofilm cell density. To determine if cefazolin resistance was phenotypic or genotypic, we measured minimum inhibitory concentration (MIC) after exposure to different cefazolin concentrations; changes in MIC would suggest genotypic features, whereas unchanged MIC would suggest phenotypic behavior. Finally, quantitative reverse transcription-polymerase chain reaction was used to quantify expression of yoeB levels between biofilm and planktonic bacteria after exposure to 1 μg/mL cefazolin for 3 hours.

          Results

          Although live biofilm mass was reduced by exposure to cefazolin when compared with biofilm mass in controls (39.2 × 10 3 ± 26.4 × 10 3 pixels), where the level after 0.5 µg/mL exposure also showed reduced mass (20.3 × 10 3 ± 11.9 × 10 3 pixels), no further reduction was seen after higher doses (mass at 1.0 µg/mL: 5.0 × 10 3 pixels ± 1.1 × 10 3 pixels; at 10.0 µg/mL: 6.4 × 10 3 ± 9.6 × 10 3 pixels; at 100.0 µg/mL: 6.4 × 10 3 ± 3.9 × 10 3). At the highest concentration tested (100 µg/mL), residual viable biofilm was present on all three materials, and there were no differences in percent biofilm survival among cobalt-chromium (18.5% ± 15.1%), polymethylmethacrylate (22.8% ± 20.2%), and polyethylene (14.7% ± 10.4%). We found that tolerance was a phenotypic phenomenon, because increasing cefazolin exposure did not result in changes in MIC as compared with controls (MIC in controls: 0.13 ± 0.02; at 0.5 µg/mL: 0.13 ± 0.001, p = 0.96; at 1.0 µg/m: 0.14 ± 0.04, p = 0.95; at 10.0 µg/m: 0.11 ± 0.016, p = 0.47; at 100.0 µg/m: 0.94 ± 0.047, p = 0.47). Expression of yoeB after 1 µg/mL cefazolin for 3 hours in biofilm cells was greater in biofilm but not in planktonic cells (biofilm: 62.3-fold change, planktonic cells: −78.8-fold change, p < 0.001).

          Conclusions

          Antibiotics are inadequate at complete removal of the biofilm from the surface of TKA materials. Results suggest that bacterial persisters are responsible for this phenotypic behavior allowing biofilm high tolerance to antibiotics.

          Clinical Relevance

          Antibiotic-tolerant biofilm suggests a mechanism behind the poor results in irrigation and débridement for acute TKA PJI.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          Staphylococcus aureus: new evidence for intracellular persistence.

          Many reports have documented that Staphylococcus aureus can invade host cells and persist intracellularly for various periods of time in cell culture models. However, it is not clear whether intracellular persistence of S. aureus also occurs in the course of infections in whole organisms. This is a subject of intense debate and is difficult to assess experimentally. Intracellular persistence would provide S. aureus with an ideal strategy to escape from professional phagocytes and extracellular antibiotics and would promote recrudescent infection. Here, we present a brief overview of the mounting evidence that S. aureus has the potential to internalize and survive within host cells.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Arrested protein synthesis increases persister-like cell formation.

            Biofilms are associated with a wide variety of bacterial infections and pose a serious problem in clinical medicine due to their inherent resilience to antibiotic treatment. Within biofilms, persister cells comprise a small bacterial subpopulation that exhibits multidrug tolerance to antibiotics without undergoing genetic change. The low frequency of persister cell formation makes it difficult to isolate and study persisters, and bacterial persistence is often attributed to a quiescent metabolic state induced by toxins that are regulated through toxin-antitoxin systems. Here we mimic toxins via chemical pretreatments to induce high levels of persistence (10 to 100%) from an initial population of 0.01%. Pretreatment of Escherichia coli with (i) rifampin, which halts transcription, (ii) tetracycline, which halts translation, and (iii) carbonyl cyanide m-chlorophenylhydrazone, which halts ATP synthesis, all increased persistence dramatically. Using these compounds, we demonstrate that bacterial persistence results from halted protein synthesis and from environmental cues.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Multiple Toxin-Antitoxin Systems in Mycobacterium tuberculosis

              The hallmark of Mycobacterium tuberculosis is its ability to persist for a long-term in host granulomas, in a non-replicating and drug-tolerant state, and later awaken to cause disease. To date, the cellular factors and the molecular mechanisms that mediate entry into the persistence phase are poorly understood. Remarkably, M. tuberculosis possesses a very high number of toxin-antitoxin (TA) systems in its chromosome, 79 in total, regrouping both well-known (68) and novel (11) families, with some of them being strongly induced in drug-tolerant persisters. In agreement with the capacity of stress-responsive TA systems to generate persisters in other bacteria, it has been proposed that activation of TA systems in M. tuberculosis could contribute to its pathogenesis. Herein, we review the current knowledge on the multiple TA families present in this bacterium, their mechanism, and their potential role in physiology and virulence.
                Bookmark

                Author and article information

                Contributors
                urishk2@upmc.edu
                Journal
                Clin Orthop Relat Res
                Clin. Orthop. Relat. Res
                Clinical Orthopaedics and Related Research
                Springer US (New York )
                0009-921X
                1528-1132
                1 February 2016
                July 2016
                : 474
                : 7
                : 1649-1656
                Affiliations
                [1 ] GRID grid.21925.3d, ISNI 0000000419369000, The Magee Bone & Joint Center, Department of Orthopaedic Surgery, , University of Pittsburgh, ; Pittsburgh, PA 15212 USA
                [2 ] GRID grid.240473.6, ISNI 0000000405439901, Department of Orthopaedics and Rehabilitation, , Penn State Hershey Medical Center, ; Hershey, PA USA
                [3 ] GRID grid.29857.31, ISNI 0000000120974281, Department of Chemical Engineering, , The Pennsylvania State University, ; University Park, PA USA
                [4 ] GRID grid.240473.6, ISNI 0000000405439901, Department of Pathology, , Penn State Hershey Medical Center and College of Medicine, ; Hershey, PA USA
                [5 ] GRID grid.21925.3d, ISNI 0000000419369000, Department of Orthopaedic Surgery, , University of Pittsburgh School of Medicine, ; Pittsburgh, PA USA
                [6 ] GRID grid.266813.8, ISNI 0000000106664105, Orthopaedics Biomechanics & Advanced Surgical Technologies Laboratory, Department of Orthopaedic Surgery and Rehabilitation, , University of Nebraska Medical Center, ; Omaha, NE USA
                [7 ] GRID grid.21925.3d, ISNI 0000000419369000, Center for Cellular and Molecular Engineering, Department of Orthopaedic Surgery, , University of Pittsburgh School of Medicine, ; Pittsburgh, PA USA
                Article
                PMC4887357 PMC4887357 4887357 4720
                10.1007/s11999-016-4720-8
                4887357
                26831479
                65fd81f5-c300-4c10-9d6e-e3619553e501
                © The Association of Bone and Joint Surgeons® 2016
                History
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000002, National Institutes of Health (US);
                Award ID: KL2 TR000146
                Award Recipient :
                Categories
                Symposium: Proceedings of the 2015 Musculoskeletal Infection Society
                Custom metadata
                © The Association of Bone and Joint Surgeons® 2016

                Comments

                Comment on this article